Elscint and Phototonix Systems link up in imaging venture:
This article was originally published in Clinica
Israeli companies Elscint and Phototonix Systems have entered into a joint venture to develop a multi-modality image processing workstation for CT, MRI and nuclear medicine. The venture, called Algotec Systems, will use a UNIX workstation with an accelerator board for fast reconstruction of images. The unit should also offer multi-planar reconstruction, angiography and 3-D imaging. Later versions will include superimposition, MRI cardiac diagnostics and dental applications.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.